Dyne Therapeutics, Inc. Common Stock DYN
$17.04
+0.35%
at last close
Analyst Consensus
- Consensus Rating
- Moderate Buy (10 Buy · 2 Hold · 1 Sell)
- Average Price Target
- $30.00
- Implied Upside
- +76.1%
- Price Target Range
- $10.00 – $47.00
- Analysts (12 mo)
- 13
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-10-28 | OppenheimerKostas Biliouris |
Downgrades | Outperform → Perform | $40 → $15 |
| 2026-09-30 | Chardan CapitalKeay Nakae |
Maintains | Buy | $38 |
| 2026-09-30 | HC Wainwright & Co.Ananda Ghosh |
Maintains | Buy | $50 → $32 |
| 2026-09-29 | Piper SandlerEdward Tenthoff |
Reiterates | Overweight | $47 |
| 2026-09-09 | Morgan StanleyMichael Ulz |
Maintains | Overweight | $45 → $36 |
| 2026-09-09 | JP MorganTessa Romero |
Downgrades | Neutral → Underweight | $17 → $10 |
| 2026-09-09 | RBC CapitalLuca Issi |
Maintains | Outperform | $35 → $30 |
| 2026-09-09 | BairdBrian Skorney |
Maintains | Outperform | $30 → $26 |
| 2026-07-31 | Morgan StanleyMichael Ulz |
Maintains | Overweight | $47 → $45 |
| 2026-07-30 | RBC CapitalLuca Issi |
Maintains | Outperform | $30 → $35 |
| 2026-07-23 | Cantor FitzgeraldEric Schmidt |
Initiates coverage on | Overweight | — |
| 2026-06-26 | TD CowenJoseph Thome |
Initiates coverage on | Buy | — |
| 2026-05-15 | Evercore ISI GroupGavin Clark-Gartner |
Maintains | Outperform | $34 → $33 |
| 2026-05-13 | BernsteinWilliam Pickering |
Maintains | Market perform | $23 → $24 |
| 2026-03-09 | Chardan CapitalKeay Nakae |
Maintains | Buy | $38 |
| 2026-03-03 | Morgan StanleyMichael Ulz |
Maintains | Overweight | $50 → $47 |
| 2026-03-03 | Chardan CapitalKeay Nakae |
Maintains | Buy | $38 |
| 2026-03-03 | HC Wainwright & Co.Ananda Ghosh |
Maintains | Buy | $60 → $50 |
| 2026-01-20 | JP MorganTessa Romero |
Maintains | Neutral | $17 → $16 |
| 2025-12-15 | Evercore ISI GroupGavin Clark-Gartner |
Maintains | Outperform | $38 → $36 |
| 2025-12-11 | StifelPaul Matteis |
Maintains | Buy | $36 → $39 |
| 2025-12-10 | OppenheimerAndreas Argyrides |
Upgrades | Perform → Outperform | $11 → $40 |
| 2025-12-09 | Morgan StanleyMichael Ulz |
Maintains | Overweight | $46 → $50 |
| 2025-12-09 | Chardan CapitalKeay Nakae |
Maintains | Buy | $38 |
| 2025-12-08 | HC Wainwright & Co.Ananda Ghosh |
Maintains | Buy | $46 → $60 |
| 2025-11-14 | JP MorganTessa Romero |
Maintains | Neutral | $18 → $17 |
| 2025-11-12 | OppenheimerAndreas Argyrides |
Maintains | Perform | $13 → $11 |
| 2025-11-06 | HC Wainwright & Co.Ananda Ghosh |
Maintains | Buy | $38 → $46 |
| 2025-11-06 | RBC CapitalLuca Issi |
Maintains | Outperform | $23 → $30 |
| 2025-10-10 | OppenheimerAndreas Argyrides |
Downgrades | Outperform → Perform | $13 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $17.04
- Market Cap
- $3.17 billion
- 52-Week Range
- $11.92 – $27.30
- Average Volume
- 2.99 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.